A collaborative research study co-led by scientists at the Icahn School of Medicine at Mount Sinai and the Liber Institute for Brain Development has for the first time identified a biological process ...

Five years after the Artemis Accords were established, key rules for operating on the moon remain unresolved, including how to respond to emergencies and how to define "safety zones" around lunar ...

Circular RNAs are the byproducts of aberrant “backsplicing.” They accumulate and cause problems in the brain with age. According to a study published March 5 in Molecular Cell, ribonuclease κ—an ...

[L-R] Baisong Mei, Anna O'Driscoll chat with City Therapeutics CEO Andy Orth. City Therapeutics, a startup whose co-founders include RNA interference drug pioneer John Maraganore, PhD, is building a ...

A SanegeneBio researcher at work in the company's lab. Genentech, a member of the Roche Group, will apply SanegeneBio’s RNA interference (RNAi) platform to develop one of the company’s RNAi programs ...

Gene knockdown is a common method for studying gene function by reducing messenger ribonucleic acid (mRNA) levels without altering the deoxyribonucleic acid (DNA). Among the available techniques, RNA ...

The Denver Broncos’ 33-30 divisional round win over the Buffalo Bills was decided to a large degree by one pass interference call that happened — and another one that should have, but didn’t.

The Fiesta Bowl matchup between No. 6 Mississippi and No. 10 Miami turned into an instant classic, with the Hurricanes coming from behind to win 31-27 and advance to the College Football Playoff ...

With six drugs approved for commercial development, Cambridge-based drugmaker Alnylam Pharmaceuticals Inc. is investing $250 million into its biomanufacturing plant in Norton. The expansion comes as ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore injured tissue. The discovery came from studying tiny molecular messages ...